Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Investigation Failures, Root Cause Problems Continue To Bedevil Manufacturers

Executive Summary

FDA and industry experts discuss avoiding old pitfalls and exploring new investigation models at FDA/PDA conference, as pharmaceutical manufacturers continue to struggle with failure investigations and discerning the root cause of quality defects.


Related Content

FY 2015 Drug GMP Warning Letters Hit Compounders and Foreign Sites
FDA’s Blizzard of Enforcement at Compounding Pharmacies Evident in GMP Warning Letters for FY 2014